Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,973 | 0 | N/A | 0 | 0 |
| Marketable Securities | 16,412 | 0 | N/A | 0 | 0 |
| Other current assets | 661 | 0 | 0 | 0 | 0 |
| TOTAL | $120,584 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 4,805 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 282 | 0 | 0 | 0 | 0 |
| TOTAL | $5,087 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $125,671 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,105 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 2,007 | 0 | N/A | 0 | 0 |
| Other current liabilities | 158 | 0 | N/A | 0 | 0 |
| TOTAL | $3,602 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 332 | N/A | N/A | N/A | N/A |
| TOTAL | $2,728 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,330 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,911 | N/A | N/A | N/A | N/A |
| Common Shares | 19 | 0 | N/A | 0 | 0 |
| Retained earnings | -37,750 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | -120 | 0 | 0 | 0 | 0 |
| TOTAL | $119,341 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $125,671 | $0 | $0 | $0 | $0 |